<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02642276</url>
  </required_header>
  <id_info>
    <org_study_id>UKCLRehab0022015</org_study_id>
    <nct_id>NCT02642276</nct_id>
  </id_info>
  <brief_title>Exercise Training in Individuals With Peripheral Arterial Disease</brief_title>
  <official_title>Influence of Different Types of Exercise Training on Selected Cardiovascular Parameters in Individuals With Peripheral Arterial Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Centre Ljubljana</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medical Centre Ljubljana</source>
  <brief_summary>
    <textblock>
      In this controlled trial, patients with peripheral arterial disease will be randomized to
      either maximal walking, submaximal walking, or usual care groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Exercise training (walking) is a recommended therapeutic intervention for patients with
      peripheral arterial disease (PAD). Studies have shown that exercise training improves walking
      distance, pain-free walking distance, endothelial function and quality of life in these
      patients. However, to date the most effective exercise training option in terms of
      improvement of cardiovascular parameters has not been clearly identified. In this controlled
      trial, patients with PAD will be randomized to either maximal walking group, submaximal
      walking group, or usual care. The aim of the study is to compare the effect of maximal vs.
      submaximal walking training programmes on i) walking ability, ii) vascular function, iii)
      arrhythmogenic potential, iv) parameters of inflammation, hemostasis and heart failure
      severity, v) health-related quality of life in individuals with PAD.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Actual">April 2017</completion_date>
  <primary_completion_date type="Actual">April 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of maximum walking distance, measured in metres</measure>
    <time_frame>3 months</time_frame>
    <description>Determined by treadmill walking test.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of flow-mediated dilatation of the brachial artery, measured in %</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of the arterial stiffness coefficient</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of the value of blood C-reactive protein, measured in mg/l</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of the value of blood fibrinogen, measured in g/l</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of the value of blood D-dimer, measured in microg/l</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of the value of blood N terminal-proBNP, measured in ng/l</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of from-the-questionnaire-obtained quality of life, measured in points</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of the ECG waves</measure>
    <time_frame>3 months</time_frame>
    <description>Estimated with digital high-resolution ECG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of the heart rate variability</measure>
    <time_frame>3 months</time_frame>
    <description>Estimated with digital high-resolution ECG</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <condition>Intermittent Claudication</condition>
  <arm_group>
    <arm_group_label>Maximal walking group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients to be randomized to the 'maximal walking group' will have exercise training sessions 3 times per week for a period of 12 weeks. They will undergo an exercise training programme consisting of 60 minutes of repetitive interval muscle training/walking up to the point of pain-free walking distance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Submaximal walking group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients to be randomized to the 'submaximal walking group' will have exercise training sessions 3 times per week for a period of 12 weeks. They will undergo an exercise training programme consisting of 60 minutes of repetitive interval muscle training/walking up to 2/3 of pain-free walking distance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients to be randomized to the 'usual care group' will undergo standard care for 12 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise training</intervention_name>
    <description>Patients to be randomized to the 'maximal walking group' or 'submaximal group' will undergo exercise training sessions 3 times per week for a period of 12 weeks.</description>
    <arm_group_label>Maximal walking group</arm_group_label>
    <arm_group_label>Submaximal walking group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosed peripheral arterial disease,

          -  Fontaine stage II,

          -  not included in a cardiovascular rehabilitation programme for at least 3 months.

        Exclusion Criteria:

          -  contraindications for physical activity,

          -  uncontrolled dysrhythmias,

          -  uncontrolled heart failure (New York Heart Association (NYHA) stage IV),

          -  unstable coronary or other arterial disease,

          -  intellectual development disorder,

          -  pregnancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Borut Jug, MD, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Centre Ljubljana, Slovenia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Medical Centre Ljubljana</name>
      <address>
        <city>Ljubljana</city>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Slovenia</country>
  </location_countries>
  <reference>
    <citation>Januszek R, Mika P, Konik A, Petriczek T, Nowobilski R, Ni≈ºankowski R. Effect of treadmill training on endothelial function and walking abilities in patients with peripheral arterial disease. J Cardiol. 2014 Aug;64(2):145-51. doi: 10.1016/j.jjcc.2013.12.002. Epub 2014 Jan 14.</citation>
    <PMID>24438856</PMID>
  </reference>
  <reference>
    <citation>Mika P, Konik A, Januszek R, Petriczek T, Mika A, Nowobilski R, Nizankowski R, Szczeklik A. Comparison of two treadmill training programs on walking ability and endothelial function in intermittent claudication. Int J Cardiol. 2013 Sep 30;168(2):838-42. doi: 10.1016/j.ijcard.2012.10.003. Epub 2012 Oct 30.</citation>
    <PMID>23117015</PMID>
  </reference>
  <reference>
    <citation>Delaney CL, Miller MD, Allan RB, Spark JI. The impact of different supervised exercise regimens on endothelial function in patients with intermittent claudication. Vascular. 2015 Dec;23(6):561-9. doi: 10.1177/1708538114558329. Epub 2014 Nov 18.</citation>
    <PMID>25406267</PMID>
  </reference>
  <reference>
    <citation>McDermott MM, Greenland P, Green D, Guralnik JM, Criqui MH, Liu K, Chan C, Pearce WH, Taylor L, Ridker PM, Schneider JR, Martin G, Rifai N, Quann M, Fornage M. D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease. Circulation. 2003 Jul 1;107(25):3191-8. Epub 2003 Jun 16.</citation>
    <PMID>12810614</PMID>
  </reference>
  <reference>
    <citation>Mika P, Wilk B, Mika A, Marchewka A, Nizankowski R. The effect of pain-free treadmill training on fibrinogen, haematocrit, and lipid profile in patients with claudication. Eur J Cardiovasc Prev Rehabil. 2011 Oct;18(5):754-60. doi: 10.1177/1741826710389421. Epub 2011 Feb 9.</citation>
    <PMID>21450630</PMID>
  </reference>
  <reference>
    <citation>Schlager O, Hammer A, Giurgea A, Schuhfried O, Fialka-Moser V, Gschwandtner M, Koppensteiner R, Steiner S. Impact of exercise training on inflammation and platelet activation in patients with intermittent claudication. Swiss Med Wkly. 2012 Aug 14;142:w13623. doi: 10.4414/smw.2012.13623.</citation>
    <PMID>22893497</PMID>
  </reference>
  <reference>
    <citation>Parmenter BJ, Dieberg G, Phipps G, Smart NA. Exercise training for health-related quality of life in peripheral artery disease: a systematic review and meta-analysis. Vasc Med. 2015 Feb;20(1):30-40. doi: 10.1177/1358863X14559092. Epub 2014 Nov 28. Review.</citation>
    <PMID>25432991</PMID>
  </reference>
  <reference>
    <citation>Gardner AW, Montgomery PS, Flinn WR, Katzel LI. The effect of exercise intensity on the response to exercise rehabilitation in patients with intermittent claudication. J Vasc Surg. 2005 Oct;42(4):702-9.</citation>
    <PMID>16242558</PMID>
  </reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2015</study_first_submitted>
  <study_first_submitted_qc>December 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2015</study_first_posted>
  <last_update_submitted>September 19, 2017</last_update_submitted>
  <last_update_submitted_qc>September 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Centre Ljubljana</investigator_affiliation>
    <investigator_full_name>Borut Jug</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>exercise training</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Intermittent Claudication</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

